These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27193822)

  • 1. FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels.
    Yao H; Rayburn ER; Shi Q; Gao L; Hu W; Li H
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):1-17. PubMed ID: 27193822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interactions between drugs and laboratory test results on diagnostic test interpretation - a systematic review.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Clin Chem Lab Med; 2018 Nov; 56(12):2004-2009. PubMed ID: 30332390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA-approved medications that impair human spermatogenesis.
    Ding J; Shang X; Zhang Z; Jing H; Shao J; Fei Q; Rayburn ER; Li H
    Oncotarget; 2017 Feb; 8(6):10714-10725. PubMed ID: 27801671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic error as a result of drug-laboratory test interactions.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Diagnosis (Berl); 2019 Mar; 6(1):69-71. PubMed ID: 30753158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.
    Rayburn ER; Gao L; Ding J; Ding H; Shao J; Li H
    J Assist Reprod Genet; 2018 Feb; 35(2):191-212. PubMed ID: 29063992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action.
    Zhang Z; Xu L; Zhang Z; Ding H; Rayburn ER; Li H
    Expert Opin Drug Saf; 2018 Dec; 17(12):1171-1183. PubMed ID: 30394114
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Cornelissen AS; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R; ;
    Clin Chem Lab Med; 2021 Jun; 59(7):1239-1245. PubMed ID: 33645171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information comparison of the effects of drugs on laboratory tests in drug labels and Young's book.
    Geerts AF; De Koning FH; Egberts TC; De Smet PA; Van Solinge WW
    Clin Chem Lab Med; 2012 Oct; 50(10):1765-8. PubMed ID: 23089706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.
    Li H; Shi Q
    Clin Pharmacokinet; 2015 May; 54(5):493-501. PubMed ID: 25701380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?
    Zhang Z; Hu W; Li L; Ding H; Li H
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28810082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time monitoring of drug laboratory test interactions: a proof of concept.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R
    Clin Chem Lab Med; 2022 Jan; 60(2):235-242. PubMed ID: 34751523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice.
    Shea MB; Stewart M; Van Dyke H; Ostermann L; Allen J; Sigal E
    Ther Innov Regul Sci; 2018 Nov; 52(6):771-777. PubMed ID: 29714570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.
    Kim T; Han N; Sohn M; Oh JM; Lee EK; Ji E; Kim IW
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):438-44. PubMed ID: 25348905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States.
    Song YK; Han N; Burckart GJ; Oh JM
    Clin Pharmacol Ther; 2020 Mar; 107(3):530-540. PubMed ID: 31544241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic biomarkers in drug labels: what do they tell us?
    Tutton R
    Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidality, Depression, and the FDA: Health Inequities and the Ethical Conduct of Research.
    Iltis AS; McCall WV; Deria R
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32023368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels.
    Conrado DJ; Rogers HL; Zineh I; Pacanowski MA
    Pharmacogenomics; 2013 Jan; 14(2):215-23. PubMed ID: 23327581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.